Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-center Study for the Clinical Response of Choline Acetyltransferase and Apolipoprotein Epsilon Gene Polymorphisms to Donepezil in Alzheimer's Disease

NCT00381381 is registered in ClinicalTrials.gov with Eisai Korea Inc. as lead sponsor.

NCT NCT00381381
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00381381 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-center Study for the Clinical Response of Choline Acetyltransferase and Apolipoprotein Epsilon Gene Polymorphisms to Donepezil in Alzheimer's Disease
Lead sponsor
Eisai Korea Inc.
Phase
Phase 4
Overall status
Completed
Start date
May 31, 2006
Completion date
December 31, 2008
Enrollment
199 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer's disease